A specialty chemical stock described by Sanjoy Bhattacharyya as the “solitary beacon of hope” has caught the attention of ace stock pickers. Motilal Oswal has conducted an expert analysis and certified that re-rating is imminent for the stock and that hefty gains can be harvested from it
Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead of being a lone wolf, she has relied on the collective wisdom of Kishore Bang and Motilal Oswal to home in on a micro-cap Pharma stock with impressive past performance and ambitious future plans
Today, when panic-stricken investors were running helter-skelter due to NAMO’s knee-jerk crackdown over their favourite stocks, the Gurus had a benign smile. Their immense wisdom had spared them once again from calamity & carnage!
Leading experts have sent the clarion call that there is a massive opportunity brewing in the specialty chemical space and that early birds stand to make large sums of money. The experts have also short-listed the stocks that are likely to be the big gainers
A mid-cap Pharma stock has become the favourite of several ace stock pickers because of it’s dominance in the market place, high RoEs, quality management and reasonable valuations. The stock is also proclaimed as a potential 100-bagger stock. Daljeet Kohli claims the stock is a good buy now because it is “ripe for re-rating“
Motilal Oswal, the founder of MOFSL, has recommended five large-cap stocks and five small-cap stocks which he believes have the potential to give multi-bagger gains and create huge wealth for their shareholders
Porinju Veliyath’s aggressive buying action appears to have been inauspiciously timed. The Company whose stock he bought has found itself on the wrong side of regulatory action. Will Porinju bail out of the stock or will he brazen it out?
Bill Ackman’s Pershing Square Hedge Fund has lost $2 Billion of its investment in Valeant Pharma on the back of allegations that Valeant is an “Enron like fraud”. If a super-savvy investor like Bill Ackman can’t get his investments right, what chance do ordinary investors have?
ET has conducted an inquiry into Dolly Khanna’s latest portfolio and the returns that it has been churning. Not surprisingly, the portfolio of multi-bagger stocks is outperforming and giving blazing returns
Basant Maheshwari has so far kept a tight lip over the rampant speculation that he has offloaded his one-time favourite stocks. Basant has now come clean and admitted to churning his portfolio
Recent Comments